Apogee Therapeutics APGE
APGE
$135.07 +1.11 (+0.83%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) Interest Income - Total (2024 - 2025)

Updated

Apogee Therapeutics' Interest Income - Total was -$8.73 million in Q4 2025, compared with -$8.68 million a year earlier.

Analysis

Apogee Therapeutics (APGE) Interest Income - Total (2024 - 2025) Analysis & Trends

For FY2025, Interest Income - Total at Apogee Therapeutics came in at -$30.03 million.

  • In earlier years, Interest Income - Total was -$34.74 million in FY2024 and -$9.02 million in FY2023.
  • The Q4 2025 figure marks the lowest quarterly Interest Income - Total since Q3 2024.
  • Per Business Quant data, APGE's Interest Income - Total in the three quarters before Q4 2025 was -$6.32 million (Q3 2025), -$7.14 million (Q2 2025) and -$7.84 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Total (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Apogee Therapeutics 10.18 Bn 7.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.73 Mn
Sep 30, 2025 -6.32 Mn
Jun 30, 2025 -7.14 Mn
Mar 31, 2025 -7.84 Mn
Dec 31, 2024 -8.68 Mn
Sep 30, 2024 -9.67 Mn
Jun 30, 2024 -10.31 Mn
Mar 31, 2024 -6.09 Mn
API Access

Apogee Therapeutics Interest Income - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-income-total&ticker=APGE&period=max&api_key=YOUR_API_KEY